Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community

BACKGROUND: People with opioid dependence and HIV are concentrated within criminal justice settings (CJS). Upon release, however, drug relapse is common and contributes to poor HIV treatment outcomes, increased HIV transmission risk, reincarceration and mortality. Extended-release naltrexone (XR-NTX...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Contemp Clin Trials
Main Authors: Di Paola, Angela, Lincoln, Thomas, Skiest, Daniel J., Desabrais, Maureen, Altice, Frederick L., Springer, Sandra A.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283549/
https://ncbi.nlm.nih.gov/pubmed/25240704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2014.09.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares